The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection) is a two-arm multi-center individual placebo-controlled randomized (2,700 participants randomized 1:1) clinical trial to reduce post-discharge surgical site infection following open colon or small bowel surgery by comparing chlorhexidine bathing plus nasal mupirocin in the 30 days following discharge to soap without antiseptic properties (placebo) and placebo nasal ointment. This trial seeks to enhance the care of the 675,000 patients annually who undergo colon and small bowel surgery by finding simple and efficacious interventions to reduce SSI.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
2,700
Used for daily showering/bathing for 30 days after hospital discharge.
Applied to each nostril twice daily for five days for the first two weeks after hospital discharge.
Used for daily showering/bathing for 30 days after hospital discharge.
Applied to each nostril twice daily for five days for the first two weeks after hospital discharge.
Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
RECRUITINGUniversity of California, Irvine Medical Center
Orange, California, United States
RECRUITINGUniversity of California, Davis Medical Center
Sacramento, California, United States
RECRUITINGUniversity of California, San Francisco Medical Center
San Francisco, California, United States
RECRUITINGTime to First Post-Discharge Surgical Site Infection
Time frame: Within 30 Days of Hospital Discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.